Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer

Xiaoguang Wang, Man Ni, Daxiong Han

Open source

DOI
10.1155/2022/3660110
Published
2022-07-08
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/3660110,
  title = {Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer},
  author = {Xiaoguang Wang and Man Ni and Daxiong Han},
  year = {2022},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2022/3660110},
  url = {https://doi.org/10.1155/2022/3660110}
}

RIS

TY  - JOUR
TI  - Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
AU  - Xiaoguang Wang
AU  - Man Ni
AU  - Daxiong Han
PY  - 2022
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2022/3660110
UR  - https://doi.org/10.1155/2022/3660110
ER  - 

APA

Wang, X., Ni, M., & Han, D. (2022). Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2022/3660110

Source records